Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

FDA accepts IND application for Tricida's TRC-101

Jan. 14, 2016

GTx initiates phase II trial of enobosarm for stress urinary incontinence

Jan. 14, 2016

Medifocus engages Kapec Design Group as lead designer of next generation of Prolieve

Jan. 14, 2016

Ardelyx reports data for RDX-022 in the treatment of hyperkalemia

Jan. 7, 2016

Lundbeck reports PDE9 inhibitors

Dec. 28, 2015

Astellas Pharma patents muscarinic M3 receptor PAMs

Dec. 24, 2015

Astellas Pharma and Kotobuki Pharmaceutical present IRAP and P-LAP inhibitors

Dec. 22, 2015

DMX-200 drug combination given FDA orphan designation for focal segmental glomerulosclerosis

Dec. 15, 2015

University of California, Oakland divulges UT-A inhibitors

Nov. 26, 2015

BTK inhibition, a potential strategy for the treatment of lupus nephritis

Nov. 26, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...